Platelet Rich Plasma

Compared with a placebo injection, platelet-rich plasma injections yielded similar outcomes at 1 year for patients with greater trochanteric pain syndrome caused by either bursitis or gluteal tendinopathy, according to published results.

Published results showed platelet concentration may impact clinical outcomes for patients who receive platelet-rich plasma injections for knee osteoarthritis, as injections with higher platelet counts were associated with superior outcomes.

According to published results, leukocyte-rich and leukocyte-poor platelet-rich plasma injections may yield comparable outcomes in the treatment of patients with knee osteoarthritis.

Published results showed both subacromial injections of platelet-rich plasma alone or combined with vitamin C may be effective treatment options for patients with partial-thickness rotator cuff tears.

Patients who received postoperative platelet-rich plasma injections after ACL reconstruction did not report significant improvements in knee symptoms or function at 1 year compared with patients who did not receive PRP.

BOSTON — According to presented results, meniscal repair with augmentation using marrow venting and platelet-rich plasma did not significantly affect patient-reported outcomes or survivorship at minimum 2-year follow-up.

While both corticosteroids and platelet-rich plasma may be effective treatments for patients with lateral epicondylitis, or tennis elbow, PRP may offer longer-term functional improvements and pain relief, according to published results.

WAILEA, Hawaii — Although it is still unknown which orthobiologics should be used to treat athletes with knee injuries, various biologic tools may be used to help identify such uses in the future, according to a presenter here.

Patients with ankle osteoarthritis who received intra-articular talocrural platelet-rich plasma injections saw no improvements in ankle pain or function during the course of 1 year, according to published results.

NEW ORLEANS — Results showed integrating clinical outcomes with laboratory analysis of biological samples may lead to a better understanding of the variable responses to platelet-rich plasma therapy for musculoskeletal conditions.